Results 11 to 20 of about 1,561,319 (123)

A Review of Antineoplastic Agents Associated Nephrotoxicity, an Understood Complication [PDF]

open access: yes, 2020
In the recent decades, the survival of children with cancer has improved dramatically. This improvement is due to use of different chemotherapeutic agents, but the majority of these drugs have kidney toxicities.
Hashemieh, Mozhgan
core   +1 more source

Ethnopharmacological Potential of Phytochemicals and Phytogenic Products against Human RNA Viral Diseases as Preventive Therapeutics

open access: yesBioMed Research International, Volume 2023, Issue 1, 2023., 2023
RNA viruses have been the most destructive due to their transmissibility and lack of control measures. Developments of vaccines for RNA viruses are very tough or almost impossible as viruses are highly mutable. For the last few decades, most of the epidemic and pandemic viral diseases have wreaked huge devastation with innumerable fatalities. To combat
Anamika Paul   +11 more
wiley   +1 more source

PRELIMINARY CHARACTERIZATION OF EXPOSURES TO ANTINEOPLASTIC AGENTS IN A DRUG PREPARATION AREA (FLUOROURACIL, CYCLOPHOSPHAMIDE, HOSPITALS.

open access: yes, 1983
PRELIMINARY CHARACTERIZATION OF EXPOSURES TO ANTINEOPLASTIC AGENTS IN A DRUG PREPARATION AREA (FLUOROURACIL, CYCLOPHOSPHAMIDE ...
ANNA MARIA DE WERK. NEAL (7987853)
core   +4 more sources

Cutaneous Adverse Reactions Due to Antineoplastic Agents [PDF]

open access: yes, 2023
Background- Cancer is a leading cause of mortality and morbidity in the world. Traditional as well as the newer targeted antineoplastic agents are associated with a wide array of Cutaneous Adverse Reactions (CARs).
Anuj Kothari, Chetna Gahlot, Kunal Jain, Rohit J. Rebello
core   +1 more source

DENDROGENIN A AND ANTINEOPLASTIC AGENTS FOR THE TREATMENT OF CHEMOSENSITIVE OR CHEMORESISTANT TUMORS

open access: yes, 2016
Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors. The invention concerns a kit-of-parts comprising 5α-hydroxy-6&bgr;-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3&bgr;-ol (Dendrogenin A) or a ...
Silvente-Poirot, Sandrine   +4 more
core   +7 more sources

Extravasation of antineoplastic agents: prevention and treatments

open access: yes, 2012
The extravasation of antineoplastic agents is an unwanted and distressing situation that can easily occur. It may cause severe and irreversible local injuries.
Rita Boschi, Elena Rostagno
core   +1 more source

Supplementary Tables – Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting System

open access: yes, 2022
 List of antineoplastic agents included in the current analysis 
Omar Abdel-Rahman (1736950)   +2 more
core   +1 more source

In Vitro Antineoplastic Effects of Zataria multiflora: A Systematic Review of Mechanisms, Selectivity, and Synergy

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
Zataria multiflora (ZM) is an aromatic plant containing various bioactive components, including phenolic compounds, flavonoids, and terpenoids. Here, we systematically review 27 articles to explore the effect of ZM on different cancer/normal cell lines.
Alireza Khanahmad   +6 more
wiley   +1 more source

Discovery of a Novel γ‐Glutamylcyclotransferase Inhibitor Plumbagin by Luminescence‐Based High‐Throughput Screening

open access: yesCancer Science, Volume 117, Issue 6, Page 1713-1723, June 2026.
A cell‐based high‐throughput screening system utilizing the luminescent probe LISA‐103 was developed to monitor γ‐glutamylcyclotransferase (GGCT) activity in cancer cells. Through this assay, plumbagin was identified as a novel GGCT inhibitor that induces cell cycle arrest and suppresses cancer cell growth. ABSTRACT γ‐Glutamylcyclotransferase (GGCT) is
Keiko Taniguchi   +10 more
wiley   +1 more source

Patient Safety in the Administration of Antineoplastic Agents and Immunotherapy of oncology treatment: scoping review

open access: yes, 2020
Patient Safety in the Administration of Antineoplastic Agents and Immunotherapy of oncology treatment: scoping review. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES) - Finance Code 001.
Patrícia Peres de Oliveira
core   +1 more source

Home - About - Disclaimer - Privacy